Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: Katelew who wrote (703389)	2/9/2020 3:32:33 PM
From: skinowski	1 Recommendation Recommended By Stock Puppy Respond to of 793914

I remember the conversation. I gave you a somewhat general reply - like, vaccinations, general precautions... But, what else can be said? Pray and hope. Dr Peng's experience is mostly ICU. When he says that 1/3 of the patients become worse during the second week, he means ICU patients, who were critical to begin with. As a matter of fact, I found his words encouraging - he mentioned that even among those extremely sick individuals the mortality is 4-5%. That’s not so bad for the most critical group with severe viral pneumonia (plus secondary infections) and organ failure. Increased secretions of cytokines will be something expected, but massive release, to the point of “storm” - will probably (and hopefully) remain rare.